Reverse-transcriptase inhibitor

Results: 328



#Item
51vol. 12 no. 4 / vol. 13 no. 1  contents 3 6 8

vol. 12 no. 4 / vol. 13 no. 1 contents 3 6 8

Add to Reading List

Source URL: img.thebody.com

Language: English - Date: 2006-09-17 23:44:10
52Pharmacology / Gilead Sciences / Organofluorides / Cyclopropanes / Bristol-Myers Squibb / Reverse-transcriptase inhibitor / Fixed-dose combination / Emtricitabine / Lamivudine / Fixed dose combination / Chemistry / Organic chemistry

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 470 COMBINATION MEDICATIONS

Add to Reading List

Source URL: www.aidsinfonet.org

Language: English - Date: 2014-01-07 15:28:36
53Fixed dose combination / Protease inhibitors / Organofluorides / Bristol-Myers Squibb / Gilead Sciences / Reverse-transcriptase inhibitor / Abacavir/lamivudine / Abacavir / Antiretroviral drug / Chemistry / Organic chemistry / Pharmacology

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 402 DRUG NAMES AND MANUFACTURERS None of these drugs can kill the HIV virus, but each class slows down the multiplication of the virus (replication)

Add to Reading List

Source URL: www.aidsinfonet.org

Language: English - Date: 2014-10-06 13:44:26
54January[removed]VOL. 9, NO. 1 M O N T H L Y

January[removed]VOL. 9, NO. 1 M O N T H L Y

Add to Reading List

Source URL: img.thebody.com

Language: English - Date: 2006-09-17 23:39:20
55TUPE0060  TMC114/r in treatment-experienced HIV patients in POWER 3: 24-week efficacy and safety analysis Molina JM,1 Cohen C,2 Katlama C,3 Grinsztejn B,4 Timerman A,5 Pedro R,6 De Meyer S,7 de Béthune M-P,7 Vangeneugde

TUPE0060 TMC114/r in treatment-experienced HIV patients in POWER 3: 24-week efficacy and safety analysis Molina JM,1 Cohen C,2 Katlama C,3 Grinsztejn B,4 Timerman A,5 Pedro R,6 De Meyer S,7 de Béthune M-P,7 Vangeneugde

Add to Reading List

Source URL: img.thebody.com

Language: English - Date: 2006-09-19 16:50:11
56AIDS InfoNet  www.aidsinfonet.org Fact Sheet Number 401A

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 401A

Add to Reading List

Source URL: www.aidsinfonet.org

Language: English - Date: 2014-10-10 11:29:11
57FAST TRACK  HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes Soo-Yon Rheea, Rami Kantorb, David A. Katzensteina, Ricardo

FAST TRACK HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes Soo-Yon Rheea, Rami Kantorb, David A. Katzensteina, Ricardo

Add to Reading List

Source URL: hivdb.stanford.edu

Language: English - Date: 2006-03-03 13:27:40
58Genotypic predictors of human immunodeficiency virus type 1 drug resistance Soo-Yon Rhee, Jonathan Taylor, Gauhar Wadhera, Asa Ben-Hur, Douglas L. Brutlag, and Robert W. Shafer PNAS published online Oct 25, 2006; doi:10.

Genotypic predictors of human immunodeficiency virus type 1 drug resistance Soo-Yon Rhee, Jonathan Taylor, Gauhar Wadhera, Asa Ben-Hur, Douglas L. Brutlag, and Robert W. Shafer PNAS published online Oct 25, 2006; doi:10.

Add to Reading List

Source URL: hivdb.stanford.edu

Language: English - Date: 2006-11-06 16:55:15
59____________________________________________________________________________________ Date: 3/02  Information, Inspiration and Advocacy for People Living with HIV/AIDS

____________________________________________________________________________________ Date: 3/02 Information, Inspiration and Advocacy for People Living with HIV/AIDS

Add to Reading List

Source URL: img.thebody.com

Language: English - Date: 2006-09-17 23:25:35
60Hindawi Publishing Corporation Scienti�ca Volume 2012, Article ID[removed], 28 pages http://dx.doi.org[removed][removed]Review Article

Hindawi Publishing Corporation Scienti�ca Volume 2012, Article ID[removed], 28 pages http://dx.doi.org[removed][removed]Review Article

Add to Reading List

Source URL: downloads.hindawi.com

Language: English - Date: 2014-05-08 09:44:45